This is the authors' abstract. We don't add key points for this paper.
Fluoroquinolones (FQs) are one of the most commonly prescribed classes of antibiotics. Although they were initially well tolerated in randomized clinical trials, subsequent epidemiological studies have reported an increased risk of threatening, severe, long-lasting, disabling and irreversible adverse effects (AEs), related to neurotoxicity and collagen degradation, such as tendonitis, Achilles tendon rupture, aortic aneurysm, and retinal detachment. This article reviews the main potentially threatening AEs, the alarms issued by regulatory agencies and therapeutic alternatives.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Barberán et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: